Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome  by Kim, Tae-Hoon et al.
International Journal of Cardiology 177 (2014) 907–911
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdImpact of ﬁnal kissing balloon inﬂation after simple stent implantation
for the treatment of non-left main true coronary bifurcation lesions in
patients with acute coronary syndromeTae-Hoon Kim a,1, Hyun Jong Lee a,1, Ho-Jun Jang a, Je Sang Kim a, Jin Sik Park a, Rak Kyeong Choi a,
Young Jin Choi a, Won-Heum Shim a, Young Moo Ro a, Cheol Woong Yu b,⁎, Sung Woo Kwon c,d,⁎⁎
a Division of Cardiology, Department of Internal Medicine, Sejong General Hospital, Bucheon, Republic of Korea
b Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea
c Division of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea
d Department of Medicine, Yonsei University Graduate School, Seoul, Republic of Korea⁎ Correspondence to: C.W. Yu, Cardiovascular Center, A
College of Medicine, 126-1, Anam-dong 5ga, Seongbuk-gu
⁎⁎ Correspondence to: S.W. Kwon, Division of Cardio
Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu
E-mail addresses: ycw717@naver.com (C.W. Yu), kwo
(S.W. Kwon).
1 The ﬁrst two authors equally contributed to this stud
http://dx.doi.org/10.1016/j.ijcard.2014.10.029
0167-5273/© 2014 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 28 June 2013
Received in revised form 11 August 2014
Accepted 18 October 2014
Available online 23 October 2014
Keywords:
Bifurcation
Drug-eluting stent
Angioplasty
Acute coronary syndrome
Prognosis
Objectives:We sought to evaluate the impact of ﬁnal kissing balloon inﬂation (FKBI) after simple stent implantation
for the treatment of non-leftmain true coronary bifurcation lesions in patientswith acute coronary syndrome (ACS).
Background:Whether FKBI should be mandatory after simple stent implantation for the treatment of coronary
bifurcation lesion is controversial. Besides, ACS patientswho have undergone bifurcation percutaneous coronary
interventionwith simple stent implantationmay experienceworse prognosis compared to stable angina pectoris
patients.
Methods: Two hundred and ﬁfty one eligible patients (67.7% male, mean age 61.7 ± 10.4 years) were enrolled.
The study populationwas divided into two groups according to the performance of FKBI. The primary end points
weremajor adverse cardiac event (MACE); target lesion revascularization (TLR), non-fatal myocardial infarction
(MI) and cardiac death during the follow-up period.
Results: Over a mean follow-up period of 3.0 ± 1.9 years, there were 29 MACEs (10 TLR, 6 non-fatal MI, and 13
cardiac deaths), representing an event rate of 11.6%. Kaplan–Meier survival analysis revealed that FBKI grouphad
favorable outcome compared to non-FKBI group with regard to hard events (p = 0.010) as well as composite
MACEs (p = 0.008). In multivariable analysis, FKBI was a signiﬁcant predictor of composite MACEs [hazard
ratio 0.398 (95% conﬁdence interval 0.190–0.836, p = 0.015)] and hard events [hazard ratio 0.325 (95% conﬁ-
dence interval 0.130–0.811, p = 0.016)].
Conclusions: In terms of prognosis, performing FKBI after simple stent implantation for the treatment of non-left
main true coronary bifurcation lesions may be mandatory in ACS patients.nam
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license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Percutaneous coronary intervention (PCI) of bifurcation lesions re-
mains themain concern since it is associated with increased procedural
costs, increased use of contrast media, longer procedural time, more ra-
diation hazard exposure, greater complication rates, and worse out-
come compared to PCI of simple lesions [1]. In the contemporary
drug-eluting stent (DES) era of treatment of bifurcation lesions, theHospital, Korea University
ul, Republic of Korea.
, Department of Internal
eon, Republic of Korea.
r@gmail.com
Ltd. This is an open access articlprovisional side branch (SB) stenting strategy has emerged as the pre-
ferred bifurcation treatment strategy, although complex stent implanta-
tion still may be beneﬁcial in select patients [2,3]. When performing PCI
for the treatment of coronary bifurcation lesions, ﬁnal kissing balloon
inﬂation (FKBI) after complex stent implantation is generally consid-
ered mandatory [4]. However, concerning prognosis, whether FKBI
should be mandatory after simple stent implantation is controversial
[5,6]. Clinical presentation should also be contemplated when
performing bifurcation PCI, since a recent study suggested that acute
coronary syndrome (ACS) patients who underwent bifurcation PCI
with simple stent implantation hadworse prognosis compared to stable
angina pectoris patients [7]. Little data are available concerning the im-
pact of performing FKBI after simple stent implantation for the treat-
ment of non-left main true bifurcation lesions in ACS patients.
Therefore, we sought to evaluate the impact of performing FKBI aftere under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Fig. 1. Flow diagram of the study population. Abbreviations. DES = drug-eluting stent;
FKBI = ﬁnal kissing balloon inﬂation.
Table 1
Baseline clinical characteristics of the study population (n = 251).
Non-FKBI
(n = 69)
FKBI
(n = 182)
p-Value
Age (years) 60.9 ± 10.6 62.0 ± 10.3 0.420
Male gender, n (%) 49/69 (71.0%) 121/182 (66.5%) 0.493
Smoking, n (%) 27/69 (39.1%) 54/182 (29.7%) 0.152
Diabetes, n (%) 19/69 (27.5%) 57/182 (31.3%) 0.560
Hypertension, n (%) 46/69 (66.7%) 117/182 (64.3%) 0.724
Dyslipidemia, n (%) 48/69 (69.6%) 110/182 (60.4%) 0.181
Renal insufﬁciency, n (%) 3/69 (4.3%) 3/182 (1.6%) 0.211
Prior MI, n (%) 6/69 (8.7%) 6/182 (3.3%) 0.073
Prior PCI, n (%) 14/69 (20.3%) 26/182 (14.3%) 0.246
Prior CABG, n (%) 0/69 (0%) 1/182 (0.5%) 0.537
LVEF (%) 60.6 ± 13.7 58.8 ± 12.6 0.350
Clinical presentation 0.109
Unstable angina, n (%) 54/69 (78.3%) 123/182 (67.6%)
NSTEMI, n (%) 10/69 (14.5%) 27/182 (14.8%)
STEMI, n (%) 5/69 (7.2%) 32/182 (17.6%)
CAD extent 0.756
1VD, n (%) 28/69 (40.6%) 77/182 (42.3%)
2VD, n (%) 24/69 (34.8%) 68/182 (37.4%)
3VD, n (%) 17/69 (24.6%) 37/182 (20.3%)
TLR, n (%) 4/69 (5.8%) 6/182 (3.3%) 0.366
Hard events, n (%) 10/69 (14.5%) 9/182 (4.9%) 0.011
MACE, n (%) 14/69 (20.3%) 15/182 (8.2%) 0.008
Data are expressed as number (%) or mean ± standard deviation.
Abbreviations. CABG = coronary artery bypass graft surgery; CAD = coronary artery
disease; FKBI = ﬁnal kissing balloon inﬂation; LVEF = left ventricular ejection frac-
tion; MI = myocardial infarction; NSTEMI = non-ST elevation myocardial infarc-
tion; PCI = percutaneous coronary intervention; STEMI = ST elevation myocardial
infarction; VD = vessel disease.
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nary bifurcation lesions in ACS patients.
2. Materials and methods
2.1. Study design and patient selection
The Sejongbifurcation drug-eluting stent (DES) registry is a single center registry ded-
icated to bifurcation lesion PCI with DES, which compiled data from April 2003 to January
2011 at Sejong General Hospital. The inclusion criteria were 1) coronary bifurcation le-
sions treated with DES, 2) main vessel (MV) diameter ≥2.5 mm, and 3) SB diameter
≥2.0mm. The exclusion criteriawere 1) life expectancy b1 year, and 2) allergy to contrast
agent or any of the drugs used (aspirin and clopidogrel).
This study was conducted to evaluate the impact of FKBI after simple stent implanta-
tion for the treatment of non-leftmain true coronary bifurcation lesions inACS patients. Of
a total of 898 patients, 90 patientswere excluded since they had undergone complex stent
implantation. Next, 143 patients were excluded since the bifurcation lesions were at the
left main vessels. Then, 330 patients were excluded since the bifurcation lesions were
not true [Medina classiﬁcation type (1.1.0), (1.0.0), (0.1.0), (0.0.1)]. Afterwards, 84 pa-
tients were excluded since their clinical presentations were not ACS. Finally, this study
population consisted of the remaining 251 eligible patients (67.7% male, mean age
61.7 ± 10.4 years) who undergone simple stent implantation for the treatment of non-
left main true coronary bifurcation lesions. The patients were divided into two groups;
1) non-FKBI group (n = 69) and 2) FKBI group (n = 182) (Fig. 1). Institutional review
committee approval and informed consent was obtained.
2.2. Simple stent implantation
All patients received aspirin (200–300 mg) and clopidogrel (300–600 mg) unless
these antiplatelet medications had previously been administered. Intravenous heparin
was administered during the procedure. The access site, type of DES, use of intravascular
ultrasound, and glycoprotein IIb/IIIa receptor inhibitors were all at the operator's discre-
tion. The decisions whether or not to perform FKBI or not was alsomade by the individual
operator. After PCI, lifelong aspirin (≥100 mg/day) and clopidogrel (75 mg/day) for
12 months were recommended.
2.3. Data collection and analysis
Clinical, angiographic, procedural data and follow-up data were collected using elec-
tronic medical record review and/or standardized telephone interviews. All baseline and
procedural coronary angiogramswere reviewed and analyzed quantitatively at the angio-
graphic core laboratory (Sejong General Hospital, Bucheon, Korea) using standard deﬁni-
tions [8]. Quantitative coronary angiographicmeasurements of the bifurcation lesionwere
obtained in three segments: proximal MV segment, distal MV segment, and SB. In the
main vessel segments, measurements were obtained in the stent and within 5 mm of
proximal and distal margins to the MV stent. In the SB, the ﬁrst 5 mm of the SB was
used for analysis. Medina classiﬁcation type (1.1.1), (1.0.1) and (0.1.1) lesions were de-
ﬁned as true bifurcation lesions [9]. Angiographic restenosis was deﬁned as diameter ste-
nosis≥50%within a previously stented segment (stent andwithin 5mmof stent proximaland distal) at the follow-up angiogram. Angiographic success was deﬁned as a ﬁnal resid-
ual stenosis b30% with Thrombolysis In Myocardial Infarction ﬂow grade 3 in either the
MV or the SB.2.4. Endpoint determination and follow-up data acquisition
Major adverse cardiovascular events (MACEs) were deﬁned as target lesion revascu-
larization (TLR), non-fatal myocardial infarction (MI) or cardiac death. Hard events were
deﬁned as composite of non-fatal MI and cardiac death. TLR was deﬁned as repeat revas-
cularization of the lesionwithin 5mm of deployed stent or bypass graft surgery of the tar-
get vessel. Diagnosis of non-fatalMI required the presence of at least two of the following:
characteristic chest pain, elevated cardiac enzymes, or electrocardiographic alterations in-
dicative ofMI. Cardiac deathwas deﬁned as death caused by acuteMI, ventricular arrhyth-
mias, refractory heart failure, or cardiogenic shock. Patient follow-up data were collected
using electronic medical record review and/or standardized telephone interviews.2.5. Statistical analyses
Continuous data are expressed as a mean value ± standard deviation. All categorical
data are presented as a percentage or absolute number. Student's t-tests and χ2 tests were
used to assess differences between groups. Cumulative event rates as a function over time
were estimated according to theKaplan–Meiermethod, and survival curves ofMACEwere
compared using the log-rank test. Univariable Cox regression analyses were performed to
identify potential predictors of MACEs and hard events. Afterwards, variables with p-
value b 0.1 on univariable Cox regression analyseswere used formultivariable Cox regres-
sion analyses in addition to age and gender. Hazard ratios (HRs) were calculated as an es-
timate of the risk associatedwith a particular variable, with 95% conﬁdence intervals (CIs)
based on binominal distributions. All analyses were performed using SPSS software ver-
sion 18.0 (SPSS, Chicago, IL, USA). A p-value b 0.05 was considered statistically signiﬁcant.3. Results
3.1. Baseline clinical characteristics
Of the 251 eligible patients, FKBI was performed in 182 (72.5%),
while FKBI was not performed in the remaining 69 (27.5%). Baseline
clinical characteristics of the two groups are shown in Table 1. There
were no signiﬁcant differences in baseline clinical characteristics be-
tween the two groups.
Table 2
Angiographic and procedural characteristics of the study population (n = 251).
Non-FKBI
(n = 69)
FKBI
(n = 182)
p-Value
Bifurcation site 0.466
LAD 51/69 (73.9%) 140/182 (76.9%)
LCX 13/69 (18.8%) 24/182 (13.2%)
RCA 5/69 (7.2%) 18/182 (9.9%)
True bifurcation 69/69 (100%) 182/182 (100%)
Bifurcation angle 55.7 ± 19.5 54.1 ± 18.3 0.550
MV
MLD (mm) 1.10 ± 0.59 1.10 ± 0.71 0.936
MV, proximal RD (mm) 2.78 ± 0.41 2.74 ± 0.42 0.577
MV, distal RD (mm) 2.31 ± 0.54 2.30 ± 0.41 0.947
Lesion length (mm) 18.7 ± 8.9 21.2 ± 10.9 0.035
Stent diameter (mm) 2.99 ± 0.38 2.95 ± 0.31 0.502
Stent length (mm) 27.8 ± 10.1 29.0 ± 11.9 0.452
DES type 0.448
1st generation DES 40/69 (58.0%) 115/182 (63.2%)
Sirolimus-eluting stent 31/69 (44.9%) 73/182 (40.1%)
Paclitaxel-eluting stent 9/69 (13.0%) 42/182 (23.1%)
2nd generation DES 29/69 (42.0%) 67/182 (36.8%)
Zotarolimus-eluting stent 3/69 (4.3%) 26/182 (14.3%)
Everolimus-eluting stent 20/69 (29.0%) 39/182 (21.4%)
Biolimus-eluting stent 6/69 (8.7%) 2/182 (3.2%)
SB
MLD (mm) 0.69 ± 0.32 0.81 ± 0.36 0.013
SB RD (mm) 1.93 ± 0.36 2.00 ± 0.40 0.224
Lesion length (mm) 8.5 ± 5.9 9.0 ± 8.2 0.592
Transradial approach 5/69 (7.2%) 6/182 (3.3%) 0.172
IVUS 7/69 (10.1%) 6/182 (3.3%) 0.029
Gp IIb/IIIa inhibitor 4/69 (5.8%) 12/182 (6.6%) 0.818
Data are expressed as number (%) or mean ± standard deviation.
Abbreviations. DES = drug-eluting stent; FKBI = ﬁnal kissing balloon inﬂation;
Gp = glycoprotein; IVUS = intravascular ultrasound; LAD = left anterior descend-
ing coronary artery; LCX = left circumﬂex coronary artery; MLD = minimal luminal
diameter; MV = main vessel; RCA = right coronary artery; RD = reference diame-
ter; SB = side branch.
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Angiographic and procedural characteristics of the two groups are
shown in Table 2. Themost frequent bifurcation site was the left anteri-
or descending coronary artery and diagonal branch bifurcation [76.1%
(191/251)]. Therewere nodifferences in bifurcation site and bifurcation
angle between the two groups. All the bifurcation sites were true bifur-
cation lesions. Implanted stent proﬁles were similar between the two
groups. First-generation DES was implanted in 61.8% (155/251) of the
patients, mostly sirolimus-eluting stents (104/251, 41.4%). Second-
generation DES was implanted in the remaining 38.2% (96/251) of the
patients, with the majority being everolimus-eluting stents (59/251,
23.5%).
Therewere no signiﬁcant differences in quantitative coronary angio-
graphic parameters of MV between the two groups. However, the min-
imal luminal diameter of SB was larger in the FKBI group (0.81 mm)
compared to non-FKBI group (0.69 mm) (p = 0.013). Intravascular ul-
trasound was more frequently performed in the non-FKBI group [10.1%
(7/69)] compared to the FKBI group [3.3% (6/182)] (p = 0.029), al-
though intravascular ultrasound was performed in only 7.1% (13/251)
of the patients. Glycoprotein IIb/IIIa inhibitors were used during the
procedure in 6.4% (16/251) of the patients, with no difference in usage
between the two groups.Fig. 2. Comparison of Kaplan–Meier survival curves of the study population between non-
FKBI group and FKBI group. (a) Composite MACEs (TLR, non-fatal MI and cardiac death).
(b) Hard events (non-fatal MI and cardiac death). Abbreviations. FKBI= ﬁnal kissing bal-
loon inﬂation; MI = myocardial infarction; TLR = target lesion revascularization.3.3. Clinical outcome
During a mean follow-up period of 3.0 ± 1.9 years, follow-up coro-
nary angiography was performed in 47.8% (120/251) of the patients.
Overall, there were 29 MACEs (10 TLR, 6 non-fatal MI, and 13 cardiac
deaths), representing an event rate of 11.6%. The TLR rate of 5.8% (4/
69) for the non-FKBI group vs. 3.3% (6/182) for the FKBI group wasnot statistically signiﬁcant (p= 0.366). The hard event rate was signif-
icantly higher (p = 0.011) in the non-FKBI group [14.5% (10/69)] than
the FKBI group [4.9% (9/182)] for the FKBI group. Similarly, the non-
FKBI group displayed signiﬁcantly higher (p = 0.008) composite
MACE rate [20.3% (14/69)] than the FKBI group [8.2% (15/182)].
Kaplan–Meier survival analysis revealed an association of FKBI with fa-
vorable outcome with regard to composite MACEs [8.2% (15/182) for
the FKBI group vs. 20.3% (14/69) for the non-FKBI group, p = 0.008]
[Fig. 2(a)]. Moreover, the hard event rate was signiﬁcantly lower
(p = 0.010) in the FKBI group [4.9% (9/182)] compared to the non-
FKBI group [14.5% (10/69)] [Fig. 2(b)]. In addition, age and gender ad-
justed multivariable Cox regression analysis revealed that performing
FKBI after simple stent implantation for the treatment of non-left
main true bifurcation lesions in ACS patients was a signiﬁcant predictor
of composite MACEs [hazard ratio 0.398 (95% conﬁdence interval
0.190–0.836, p= 0.015)] and hard events [hazard ratio 0.325 (95% con-
ﬁdence interval 0.130–0.811, p= 0.016)] (Table 3). Furthermore, cardi-
ac death rate was lower in the FKBI group [3.3% (6/182)] compared to
the non-FKBI group [10.1% (7/69)] with statistical signiﬁcance [hazard
ratio 0.325 (95% conﬁdence interval 0.107–0.986, p= 0.047)] (Table 3).
Table 3
Prognostic impact of performing FKBI after simple stent implantation in ACS patients.
Non-FKBI (n = 69) FKBI (n = 182) Unadjusted HR (95% CI) p-Value Adjusted HRa (95% CI) p-Value
Cardiac death 7 (10.1) 6 (3.3) 0.324 (0.107–0.980) 0.046 0.325 (0.107–0.986) 0.047
Non-fatal MI 3 (4.3) 3 (1.6) 0.307 (0.061–1.531) 0.150 0.324 (0.065–1.626) 0.171
Hard event (non-fatal MI and cardiac death) 10 (14.5) 9 (4.9) 0.321 (0.129–0.798) 0.014 0.325 (0.130–0.811) 0.016
Deﬁnite or probable ST 1 (2.8) 2 (1.9) 0.658 (0.060–7.259) 0.733 0.692 (0.060–7.994) 0.768
TLR 4 (5.8) 6 (3.3) 0.541 (0.149–1.960) 0.350 0.589 (0.163–2.124) 0.418
Composite MACEb 14 (20.3) 15 (8.2) 0.381 (0.182–0.798) 0.011 0.398 (0.190–0.836) 0.015
Values are expressed as n (%).
Abbreviations. CI = conﬁdence interval; FKBI = ﬁnal kissing balloon inﬂation; HR = hazard ratio; MACE = major adverse cardiac event; MI = myocardial infarction; ST = stent
thrombosis; TLR = target lesion revascularization.
a Adjusted for age and gender.
b Composite MACE including TLR, non-fatal MI and cardiac death.
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We evaluated the impact of FKBI after simple stent implantation for
the treatment of non-left main true coronary bifurcation lesions in ACS
patients. The principal ﬁndings in this study are as follows: 1) FKBI after
simple stent implantation for the treatment of non-left main true coro-
nary bifurcation lesions was associated with favorable outcome in ACS
patients with regard to the prognosis; 2) In ACS patients, performing
FKBI after simple stent implantation for the treatment of non-left
main true coronary bifurcation lesions was a signiﬁcant factor in
predicting MACE, especially hard events consisting of non-fatal MI and
cardiac death. Taken together, we have the notion that our study re-
vealed the virtue of performing FKBI after simple stent implantation
for the treatment of non-left main true coronary bifurcation lesions in
ACS patients.
4.1. Prognostic value of performing FKBI for treatment of coronary bifurca-
tion lesions after simple stent implantation in ACS patients
In the treatment of coronary bifurcation lesions, FKBI after complex
stent implantation is generally considered mandatory [4]. However,
the necessity of performing FKBI after simple stent implantation is still
under dispute. FKBI after simple stent implantation in coronary bifurca-
tion lesionsmay bebeneﬁcialwith regard to decreasing angiographic SB
restenosis rates [5]. On the contrary, FKBI after simple stent implanta-
tion for the treatment of coronary bifurcation lesions may be harmful
in terms of increasing the TLR rates ofMV [6]. However, both these stud-
ies failed to document the prognostic impact of FKBI after simple stent
implantation dealing with hard events such as cardiac death or non-
fatal MI and can be justiﬁably criticized asmainly accounting for the dif-
ferences of repeated PCI rates (i.e. procedure-relatedMACE), not biolog-
ical events.
Previous compelling studies dealing with the value of FKBI (after
simple stent implantation for the treatment of coronary bifurcation le-
sions) consisted of patients with diverse clinical presentations [5,6].
The majority of patients in these two studies had stable angina pectoris
as their clinical presentations. However, a recent study reported that
ACS patients who had undergone simple stent implantation for the
treatment of coronary bifurcation lesions were associated with worse
prognosis when compared to stable angina pectoris patients [7].
On thebasis of these conﬂicting reports, we evaluated theprognostic
impact of performing FKBI after simple stent implantation for the treat-
ment of non-leftmain true bifurcation lesions in ACS patients. Presently,
FKBI after simple stent implantation for the treatment of non-left main
true bifurcation lesions was associated with favorable outcome com-
pared to the non-FKBI group. The major difference of MACE rates be-
tween the two groups was mainly due to increased hard event (non-
fatal MI and cardiac death) rate in the non-FKBI group. Besides, the
data demonstrated that cardiac mortality rate as well as hard event
rate was higher in the non-FKBI group. Thus, the data reveal that
performing FKBI after simple stent implantation in ACS patients hadits advantages with regard to the prediction of MACE, especially biolog-
ical events.4.2. In-depth comparisons with previous studies
The several aforementioned studies dealtwith the value of FKBI after
simple stent implantation for the treatment of coronary bifurcation le-
sions: the Nordic–Baltic Bifurcation Study III (Nordic III), and the other
is COronary BIfurcation Stent (COBIS) registry study [5,6]. The Nordic
III study reported no difference of performing FKBI after simple stent
implantation in terms of prognosis, but a potential beneﬁt of FKBI
after simple stent implantation in coronary bifurcation lesions with re-
gard to decreasing angiographic SB restenosis rates [5]. The study was
a randomized controlled trial. However, the follow-up period was
short (6–8 months), and almost three-quarters of the patientswere sta-
ble angina pectoris – patients with relatively at lower risk compared to
ACS patients –making it difﬁcult to differentiate the prognostic value of
FKBI between the two groups in predicting hard events. It may be that
most of the study population had undergone follow-up coronary angi-
ography for this reason. In addition, only about half of the patients had
true bifurcation lesions. Therefore, the prognostic impact of performing
FKBI might be attenuated. COBIS demonstrated that performing FKBI
after simple stent implantation was associated with worse prognosis
mainly due to increased TLR rate of theMV [6]. The authors did not rec-
ommend routine FKBI after simple stent implantation, since the proce-
dure might cause harm. However, the authors could not discriminate
the prognostic impact of FKBI, since there were no differences of hard
event rates including non-fatal MI, cardiac death, and stent thrombosis.
Of note, not all the patients in their study had true bifurcation lesions,
but about 70% of the patients had true bifurcation lesions, while the re-
maining 30% did not have true bifurcation lesions. Moreover, FKBI was
performed in less than one-third of the patients.
Compared with both abovementioned studies, the strength of our
study is its greater homogeneity in aspects of clinical presentation (all
patients with ACS), angiographic (all patients with non-left main ‘true’
bifurcation lesions), and other clinical characteristics. Furthermore,
our study has an advantage of a longer follow-up period (3 years),
which enabled the discrimination of the prognostic value of performing
FKBI not only in terms of a soft event such as TLR, but also for hard
events like non-fatal MI and cardiac death. Compared with the COBIS
study, FKBI was performed more frequently (72.5%) in our study. Both
the COBIS study and our study were not randomized trials, and conse-
quently the performance of FKBI was left to the operator's discretion.
Probably, FKBI was performed in more select cases in the COBIS study
and less select cases in our study. This difference in FKBI performance
rates may account for the dissimilarity of our study results compared
to the COBIS study results. Indeed, it may be that the results of COBIS
study may support the idea that it is not the performance of FKBI per
se, but the situation that affects the operator's discretion to perform
FKBI might be associated with worse prognosis.
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ACS patients
FKBI may provide scaffolding for the SB ostium, preserve access to
the SB, or optimize stent architecture [10]. Hence, performing FKBI
after simple stent implantation is generally considered beneﬁcial in
terms of SB salvage, although the clinical signiﬁcance of SB revasculari-
zation after FKBI is still under dispute [5]. In terms of SB compromise
after MV stenting, carina shift as well as plaque shift was considered
as the possible mechanisms [10–12]. The carina shift may be the main
mechanism of SB compromise after MV stenting [13,14]. However, in
these studies, the populationmainly presented as stable angina pectoris
[13,14]. In ACS patients, the characteristics of plaque tend to be softer
compared to stable angina pectoris patients. Accordingly, SB compro-
mise due to plaque shift may be more prominent in ACS patients, and
consequently, may contribute to hemodynamic SB compromise more
signiﬁcantly compared to stable angina pectoris patients. Therefore,
performing FKBI after simple stent implantation may be a reasonable
practice for the treatment of non-left main true bifurcation lesions in
ACS patients in this respect.
With regard to the impact of performing FKBI on proximal MV in
ACS patients, FKBI can be a double edged sword. FKBI may be disad-
vantageous due to the increase of the TLR rate of proximal MV,
whereas FKBI may have the advantage of decreasing proximal MV
stent malapposition. A bench study reported that FKBI after MV
stenting may lead to stent deformation, polymer damage and de-
creased metal-to-artery ratio, which might reduce the ratio of drug
application and impair the anti-proliferative effect of DES [15]. This
study may support the disadvantage of performing FKBI on proximal
MV after MV stenting, since stent deformation, polymer damage and
decreased metal-to-artery ratio may increase the TLR rate of MV.
However, in the DES era, stent restenosis has markedly decreased
relative to the bare metal stent era. In fact, stent thrombosis due to
delayed neo-endothelialization and stent malapposition is an
emerging concern in the contemporary DES era. Moreover, stent
thrombosis is more fatal than stent restenosis, and is more likely to
be related to biological events (non-fatal MI and cardiac death).
Stent malapposition occursmore frequently in ACS patients than sta-
ble angina pectoris patients, since the adrenergic vasoconstriction
leads to an underestimation of the reference vessel size, stent
under-expansion and recoil, and because thrombus dissolution cre-
ates a gap between the stent and the vessel wall [16]. These features
may give rise to the increased risk of stent thrombosis. In addition, in
the aforementioned bench stent deformation study, proximal MV
stent luminal area increased signiﬁcantly after FKBI [15]. Therefore,
in ACS patients, performing FKBI after MV stenting may lower the
risk of stent malapposition which is prone to the risk of stent throm-
bosis, in terms of ‘proximal optimization’.
4.4. Limitations
Several limitations of the current study should be acknowledged.
First, the study was performed at a single center in Korea, and consisted
of a Korean patient population. Second, this was an observational study.
Treatment of coronary bifurcation lesions either to perform FKBI or not
was not randomized, but was performed at the discretion of the opera-
tors. Third, approximately one-half of the patients had undergone
follow-up coronary angiography. Therefore, there might be criticism
for the lack of reporting data thoroughly revealing the mechanisms of
non-fatal MI, in particular the incidence of deﬁnite or probable stent
thrombosis.5. Conclusions
In terms of prognosis, performing FKBI after simple stent implanta-
tion for the treatment of non-left main true coronary bifurcation lesions
may be mandatory in ACS patients.Acknowledgments
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